Ameriprise Financial, Inc. 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-10 2:14 pm Sale | 2024-04-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | -7,505,539 (Position Closed) | Filing |
| 2024-02-14 10:55 am Purchase | 2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 7,505,539 16.910% | 7,237,908 (+2704.44%) | Filing |
| 2023-04-10 1:37 pm Purchase | 2023-02-28 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 267,631 18.220% | 86,139 (+47.46%) | Filing |
| 2023-01-10 12:12 pm Sale | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 181,492 12.350% | -71,512 (-28.27%) | Filing |
| 2022-05-11 3:01 pm Purchase | 2022-05-06 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 253,004 17.560% | 18,043 (+7.68%) | Filing |
| 2022-01-21 3:25 pm Purchase | 2021-12-27 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 234,961 20.750% | 39,639 (+20.29%) | Filing |
| 2021-09-10 10:31 am Purchase | 2021-08-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 195,322 17.260% | 64,594 (+49.41%) | Filing |
| 2021-01-11 11:46 am Purchase | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 130,728 12.060% | 130,728 (New Position) | Filing |